Cui Zhi-Hui, Zhang Hua, Zheng Feng-Hao, Xue Jun-Hao, Yin Qing-Hong, Xie Xiao-Lei, Wang Yu-Xuan, Wang Tao, Zhou Li, Fang Ge-Min
School of Life Science, Institutes of Physical Science and Information Technology, Institute of Health Sciences, Anhui University, Hefei, 230601, P. R. China.
University of Science and Technology of China, Hefei 230026, P. R. China.
Org Biomol Chem. 2024 Dec 18;23(1):188-196. doi: 10.1039/d4ob01624f.
We report a sortase-based site-specific antibody-drug conjugation strategy, which involves an affinity peptide-directed acyl transfer reaction and sortase-mediated peptide ligation. Through the affinity peptide-mediated acyl transfer reaction, an LPXTG-containing peptide is conjugated to a specific Lys side chain of an antibody. Under the assistance of sortase, a protein drug bearing a GG motif reacts specifically with the LPXTG moiety to produce an antibody-drug conjugate. Our strategy for antibody conjugation can be applied not only to chemically synthesized drugs, but also to biologically expressed proteins, and will provide a new sortase-based strategy for the preparation of antibody-drug conjugates.
我们报道了一种基于分选酶的位点特异性抗体-药物偶联策略,该策略涉及亲和肽导向的酰基转移反应和分选酶介导的肽连接。通过亲和肽介导的酰基转移反应,一个含LPXTG的肽与抗体的特定赖氨酸侧链偶联。在分选酶的协助下,带有GG基序的蛋白药物与LPXTG部分特异性反应,生成抗体-药物偶联物。我们的抗体偶联策略不仅可以应用于化学合成药物,还可以应用于生物表达的蛋白质,并将为制备抗体-药物偶联物提供一种基于分选酶的新策略。